US FDA Warns Of Severe Bleeding, Hematoma Risks With Baxter Vascu-Guard Patch
Executive Summary
The agency issued a warning of multiple severe bleeding and hematoma adverse events associated with Baxter International’s Vascu-Guard peripheral vascular patch, including three potentially linked fatalities.
You may also be interested in...
Admedus CEO Ready To Transform Company Again With TAVR
The ups, downs – and nearly outs – of ASX-listed health technologies manufacturer and distributor Admedus have made compelling reading in the past two years, but CEO Wayne Paterson has brought a competitive edge to a company that was lacking focus. Now he is looking to raise the bar again, aiming to use the company's proprietary Adapt patch technology in the TAVR space, while also pressing on with strategic plans for the therapeutic vaccines portfolio and adding scale.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.
HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency
At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.